Arthrex, Inc. v. Hilton

CourtDistrict Court, M.D. Florida
DecidedMarch 8, 2022
Docket2:21-cv-00850
StatusUnknown

This text of Arthrex, Inc. v. Hilton (Arthrex, Inc. v. Hilton) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Arthrex, Inc. v. Hilton, (M.D. Fla. 2022).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA FORT MYERS DIVISION

ARTHREX, INC.,

Plaintiff,

v. Case No: 2:21-cv-850-JLB-NPM

JEREMY CHARLES HILTON, an individual, and PARAGON 28, INC., a Delaware corporation,

Defendants.

ORDER This matter comes before the Court on a Motion for Preliminary Injunction filed by Plaintiff Arthrex, Inc. (“Arthrex”) as well as two Motions to Dismiss filed by Defendants Jeremy Charles Hilton (“Mr. Hilton”) and Paragon 28, Inc. (“Paragon”), asserting that this Court does not have personal jurisdiction over them. Paragon has filed a response in opposition to Arthrex’s Motion for Preliminary Injunction. Arthrex has filed Responses in opposition to Hilton’s and Paragon’s motions, and Paragon has filed a Reply. The Court has also conducted an evidentiary hearing and carefully reviewed the entire record, including the myriad exhibits submitted by all parties. (Doc. 35; Doc. 37.) After considering all of the relevant materials, the Court finds, for the reasons outlined below, that it has personal jurisdiction over Mr. Hilton, but it does not have personal jurisdiction over Paragon. As such, Mr. Hilton’s Motion to Dismiss (Doc. 30) is DENIED, and Paragon’s Motion to Dismiss (Doc. 31) is GRANTED. The Court also finds that Arthrex has failed to sufficiently establish justification for the entry of a preliminary injunction at this time. Accordingly,

Arthrex’s Request for Preliminary Injunction (Doc. 2) is DENIED. BACKGROUND Arthrex is a “leading designer and manufacturer of orthopedic surgical products and related medical training,” which has its principal place of business in Naples, Florida. (Doc. 1 at ¶¶ 1, 8.) One of Arthrex’s many lines of business is the design and development of products related to the foot and ankle. (Id. at ¶¶ 22–23.)

Arthrex sells these products nationwide and internationally via a network of customer contacts as well as proprietary sales strategies, training methods, pricing procedures, and marketing materials. (Id. at ¶¶ 24, 27.) Paragon is a medical device company focused exclusively on creating orthopedic surgical products for the foot and ankle. (Id. at ¶¶ 29–31.) Paragon’s principal place of business is in Englewood, Colorado. (Id. at ¶ 10; Doc. 37 at 54.) There are similarities between Paragon’s products and Arthrex’s products, and the

two companies compete directly for the same clients and entities in the same geographical regions. (Doc. 1 at ¶¶ 31, 33.) Arthrex and Paragon “often submit bids and respond to requests for proposals from the same potential clients/accounts.” (Id. at ¶ 33.) In addition to their overlapping businesses, Arthrex and Paragon are linked by Mr. Hilton. Mr. Hilton, a Colorado resident, is a former Area Manager for National Accounts at Arthrex who resigned from Arthrex in September 2021 to take a job at Paragon. (Id. at ¶¶ 1, 3, 9.) In his role at Arthrex, Mr. Hilton managed approximately eighty-two accounts throughout fourteen states in the central United

States. (Id. at ¶¶ 50, 53.) He “often handled multi-state and national accounts within the foot and ankle space.” (Id. at ¶ 46.) This position gave him access to Arthrex’s pricing and sales tactics, customer contacts and preferences, and specific discounts and rebates offered to each of Arthrex’s clients. (Id. at ¶ 48.) On January 16, 2017, Mr. Hilton signed1 an Employment Agreement with Arthrex, which contained “restrictive covenants, including confidentiality/non-

disclosure, non-competition, and non-solicitation of customers and employees.” (Id. at ¶ 38.) In relevant part, the Employment Agreement created a one-year restricted period following the cessation of Mr. Hilton’s employment with Arthrex during which he is prohibited from having any involvement2 with an Arthrex competitor.

1 Mr. Hilton testified that while he does not deny electronically signing his Employment Agreement, he does not recall doing so. (Doc. 37 at 34.) Nevertheless, Mr. Hilton’s electronic signature appears on his Employment Agreement. (See Doc. 1-2 at 12 (“Digitally Signed By: Jeremy Charles Hilton on 01/16/2017”).) Further, Arthrex’s Senior Director of Sales for the Western United States, Nathan Speer has testified that in order to digitally sign a document, an employee “ha[s] to log in and put their credentials, passwords, and then digitally sign the document,” indicating that Mr. Hilton’s signature on the Employment Agreement would require more than a rubber stamp. (Doc. 37 at 17.) Finally, Mr. Hilton has confirmed that he digitally signed several other, related employment documents on the same date and through the same digital platform through which he is alleged to have signed his Employment Agreement. (Id. at 38–39.) After evaluating Mr. Hilton’s testimony and evidence before the Court, the Court finds that notwithstanding Mr. Hilton’s lack of recollection of the event, Mr. Hilton signed the Employment Agreement.

2 The Non-Competition provision of the Employment Agreement states: Employee agrees that Employee will, during Employee’s (Id. at ¶ 43.) The Employment Agreement also includes a tolling provision, providing for the extension of the restricted period in the event of the Employment Agreement’s violation, and a provision providing for damages and injunctive relief.

(Id. at ¶¶ 44–45.) Mr. Hilton’s last day of employment with Arthrex was September 23, 2021. (Id. at ¶ 56.) On August 30 and September 23, Mr. Hilton inserted a USB/external drive into his company-owned laptop and accessed, and allegedly copied or downloaded, hundreds of documents. (Id. at ¶¶ 3–4.) Arthrex claims that the vast majority of the documents accessed were contracts between Arthrex and its

customers. (Id. at ¶ 3.) A price list, a document with data on Arthrex’s largest customers, and a marketing presentation laying out Arthrex’s business model are also believed to have been copied. (Id. at ¶ 5.) In all, Arthrex contends that Mr. Hilton’s alleged downloads contain “Arthrex’s sensitive, proprietary, and trade secret information.” (Id.) On September 27, 2021, Arthrex sent Mr. Hilton a letter, copying Paragon, to remind Mr. Hilton about his restrictive covenants and threatening legal action if he

employment or engagement by [Arthrex] and during the Restricted Period, refrain from, throughout the United States, directly or indirectly, owning, managing, operating, controlling or financing, or participating in the ownership, management, operation, control or financing of, or being connected with or having any interest in, or otherwise taking any part as a stockholder, director, officer, employee, consultant, independent contractor, partner or otherwise in, any business that is competitive with the [Arthrex] as of the date the employment terminates. (Doc. 1-2 at 7 (emphasis in original).) failed to honor them. (Id. at ¶ 57; Doc. 1-2.) Mr. Hilton responded to the letter saying that the restrictive covenants were not enforceable. (Doc. 1 at ¶ 58.) Paragon did not respond to the letter. (Id.) On October 1, 2021, Mr. Hilton

commenced his employment with Paragon. (Id. at ¶ 56.) On November 15, 2021, Arthrex filed its Complaint (Doc. 1) alleging: (1) that Mr. Hilton breached his Employment Agreement, (2) that Paragon tortiously interfered with Arthrex’s contractual relationship with Mr. Hilton and its existing and prospective customers, clients, and agents, (3) that both Mr. Hilton and Paragon misappropriated Arthrex’s trade secrets under the Defend Trade Secrets

Act (“DTSA”), 18 U.S.C. § 1836(b)(1), and (4) that both Mr. Hilton and Paragon misappropriated Arthrex’s trade secrets under the Florida Uniform Trade Secrets Act, Fla. Stat. § 688.001

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sculptchair, Inc. v. Century Arts, Ltd.
94 F.3d 623 (Eleventh Circuit, 1996)
American Red Cross v. Palm Beach Blood Bank, Inc.
143 F.3d 1407 (Eleventh Circuit, 1998)
Meier Ex Rel. Meier v. Sun International Hotels, Ltd.
288 F.3d 1264 (Eleventh Circuit, 2002)
Mutual Service Insurance v. Frit Industries, Inc.
358 F.3d 1312 (Eleventh Circuit, 2004)
State Farm Fire & Casualty Co. v. Steinberg
393 F.3d 1226 (Eleventh Circuit, 2004)
Licciardello v. Lovelady
544 F.3d 1280 (Eleventh Circuit, 2008)
Sampson v. Murray
415 U.S. 61 (Supreme Court, 1974)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Kenneth Lehrman v. Gulf Oil Corporation
500 F.2d 659 (Fifth Circuit, 1974)
Penalty Kick Management Ltd. v. Coca Cola Company
318 F.3d 1284 (Eleventh Circuit, 2003)
Tietig v. SE REGIONAL CONSTR. CORP.
557 So. 2d 98 (District Court of Appeal of Florida, 1990)
Franklin v. Brown
159 So. 2d 893 (District Court of Appeal of Florida, 1964)
Ethan Allen, Inc. v. Georgetown Manor
647 So. 2d 812 (Supreme Court of Florida, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Arthrex, Inc. v. Hilton, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arthrex-inc-v-hilton-flmd-2022.